Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00928954 · ClinicalTrials.gov registry record · NA
Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00928954 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 10 participants.
The verdict
NCT00928954, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Involuntary oscillations of the eyes (nystagmus) impairs vision so that affected patients, who have neurological disorders such as Multiple Sclerosis (MS) , cannot read or watch TV. Two medicines have been reported to suppress nystagmus and improve vision in such patients: gabapentin and memantine. The investigators set out to test which of these two drug was more effective by carrying out a double-blind cross-over study. In this way, we could determine which drug worked best in each patient.
Interventions
- DRUG memantine
- DRUG gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-02 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00928954
The ClinicalTrials.gov registry entry for NCT00928954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which memantine is the first listed.
NCT00928954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00928954 about?
NCT00928954 is a clinical study titled "Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus". Involuntary oscillations of the eyes (nystagmus) impairs vision so that affected patients, who have neurological disorders such as Multiple Sclerosis (MS) , cannot read or watch TV. Two medicines have been reported to suppress nystagmus and improve vision in such patients: gabapentin and memantine. ...
What is the current status of trial NCT00928954?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2005-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00928954?
The interventions under investigation include: memantine (DRUG), gabapentin (DRUG).
Who is sponsoring clinical trial NCT00928954?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.